EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Botulinum Toxin for Chronic Migraine: Beyond Headache Reduction and Toward Possible Cognitive Benefits

Mauro Silvestrini iD, Giovanna Viticchi, Sergio Salvemini iD, Gioacchino De Vanna, Marco Bartolini, Simona Luzzi iD

Toxins · 24.03.2026 · 18 (4) · 153

DOI: 10.3390/toxins18040153 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 24.03.2026. Verfasst von Mauro Silvestrini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy. Hauptthemen laut MEDLINE: Migraine Disorders, Botulinum Toxins, Type A, Cognition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic migraine (CM) is a debilitating neurological disorder characterized not only by persistent and severe pain, but also by substantial cognitive dysfunction that affects attention, working memory, processing speed, and executive functions. These neuropsychological disturbances are likely influenced by overall disease burden and are further modulated by affective comorbidities, sleep disturbances, and medication overuse. OnabotulinumtoxinA (BoNT-A) is an established preventive therapy for CM, supported by strong evidence of both efficacy and safety. This narrative review synthesizes findings from studies examining the relationship between BoNT-A treatment and domain-specific cognitive improvements in CM. It also outlines the potential pathophysiological mechanisms underlying these effects, summarizes the limitations of the existing literature, and highlights priorities for future research. Current evidence suggests that BoNT-A may confer neurocognitive benefits, particularly in working memory and processing speed, and that these improvements may occur partly independently of reductions in headache frequency. These favorable cognitive effects appear to be plausibly linked to decreased nociceptive “noise” and improved cortical inhibition, potentially mediated through modulation of central sensitization, nociceptive signaling, and affective states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersBotulinum Toxins, Type ACognitionHumansAnimalsChronic DiseaseCognitive EnhancementMemory, Short-Term

Stichwörter der Autor:innen

botulinum toxincentral sensitizationchronic migrainecognitioncortical inhibitionneuropsychologyprocessing speedworking memory

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin A

Autor:innen und Institutionen

  • Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy.

ORCID-Profile: Mauro Silvestrini, Sergio Salvemini, Simona Luzzi

Zitieren

APA

Silvestrini, M., Viticchi, G., Salvemini, S., De Vanna, G., Bartolini, M., & Luzzi, S. (2026). Botulinum Toxin for Chronic Migraine: Beyond Headache Reduction and Toward Possible Cognitive Benefits. Toxins, 18(4), 153. https://doi.org/10.3390/toxins18040153

Vancouver

Silvestrini M, Viticchi G, Salvemini S, De Vanna G, Bartolini M, Luzzi S. Botulinum Toxin for Chronic Migraine: Beyond Headache Reduction and Toward Possible Cognitive Benefits. Toxins. 2026;18(4):153. doi:10.3390/toxins18040153

BibTeX
@article{Silvestrini2026,
  author = {Silvestrini, Mauro and Viticchi, Giovanna and Salvemini, Sergio and De Vanna, Gioacchino and Bartolini, Marco and Luzzi, Simona},
  title = {Botulinum Toxin for Chronic Migraine: Beyond Headache Reduction and Toward Possible Cognitive Benefits},
  journal = {Toxins},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {153},
  doi = {10.3390/toxins18040153}
}
Kostenlos starten →